Molecular Profiling of GBM Patients Developed Pseudoprogression After Chemoradiation Treatment


Wenyin Shi, Joshua Palmer, Jianliang Li, Lawrence Kenyon, Jon Glass, Lyndon Kim, Maria Werner-wasik, David Andrews


Pseudoprogression (psPD) is now recognized following radiotherapy with concurrent temozolomide (RT/TMZ) for glioblastoma multiforme (GBM). The purpose of this study was to explore biomarker expression profile of GBM patients with psPD.

Download Publication